The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.